US Patent 10219921 Controlled ingrowth feature for antimigration
Patent 10219921 was granted and assigned to Boston Scientific on March, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+515 characters)
Article
Patent abstract
A tubular prosthesis that includes a scaffolding formed by at least one scaffolding filament; a cover; and at least one controlled ingrowth feature constructed and arranged to abut an inner surface of a lumen wall when the prosthesis is implanted in the body lumen. The controlled ingrowth feature may extend inwards or outwards from the prosthesis outer surface. The controlled ingrowth feature may be formed by a scaffolding filament; by a separate filament; by the cover; and combinations thereof.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Claude O. Clerc0
Colby Harris0
John A. Hingston0
Petru Andrei0
Stan R. Gilbert0
William Bertolino0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 1 Mar, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10219921 Controlled ingrowth feature for antimigration
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10219921
Date of patent
March 5, 2019
Patent application number
14873833
Date Filed
October 2, 2015
Patent primary examiner
Find more entities like US Patent 10219921 Controlled ingrowth feature for antimigration
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
